1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines
Open Access
- 6 September 2011
- journal article
- Published by Elsevier in Carbohydrate Research
- Vol. 346 (12) , 1592-1598
Abstract
No abstract availableKeywords
Funding Information
- Austrian Fonds zur Förderung der wissenschaftlichen Forschung (FWF)
- Canadian Institutes of Health Research
This publication has 20 references indexed in Scilit:
- A Fluorescent sp2‐Iminosugar With Pharmacological Chaperone Activity for Gaucher Disease: Synthesis and Intracellular Distribution StudiesChemBioChem, 2010
- 1-Deoxynojirimycins with dansyl capped N-substituents as probes for Morbus Gaucher affected cell linesCarbohydrate Research, 2010
- DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human GM1-gangliosidosis fibroblastsMolecular Genetics and Metabolism, 2010
- Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitorsBeilstein Journal of Organic Chemistry, 2010
- Chaperone Activity of Bicyclic Nojirimycin Analogues for Gaucher Mutations in Comparison with N‐(n‐nonyl)DeoxynojirimycinChemBioChem, 2009
- Iminosugars-From Synthesis to Therapeutic ApplicationsAmerican Journal of Therapeutics, 2009
- Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosisMolecular Genetics and Metabolism, 2008
- Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosisMolecular Genetics and Metabolism, 2008
- Glycosidase profiling with immobilised glycosidase-inhibiting iminoalditols—A proof-of-concept studyBioorganic & Medicinal Chemistry Letters, 2008
- Development of Adamantan-1-yl-methoxy-Functionalized 1-Deoxynojirimycin Derivatives as Selective Inhibitors of Glucosylceramide Metabolism in ManThe Journal of Organic Chemistry, 2007